Clinical Trials Browser

Nasopharyngeal Carcinoma × penpulimab × 90 days × Clear all

NCT05563480 2026-04-07

TQB2618 Injection Combined With Penpulimab Injection in the Treatment of Patients With Recurrent/Metastatic Nasopharyngeal Carcinoma

Phase 2 Completed

Nasopharyngeal Carcinoma